Literature DB >> 22422491

Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease.

Carlos Montilla1, Javier Del Pino-Montes, Eduardo Collantes-Estevez, Pilar Font, Pedro Zarco, Juan Mulero, Jordi Gratacós, Carlos Rodríguez, Xavier Juanola, Jose Luis Fernández-Sueiro, Raquel Almodovar.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is generally observed in young patients but can occur later in life or in persons ≥ 50 years of age. Our objective was to characterize the clinical features of late-onset AS in a large multicenter national cohort.
METHODS: We studied late-onset AS in the National Registry of Spondyloarthritis of the Spanish Society of Rheumatology (REGISPONSER database) cohort (n = 1257), of whom 3.5% had onset at age ≥ 50 years versus a control group with onset at < 50 years.
RESULTS: There were no differences between late-onset and early-onset AS according to sex and family history of spondyloarthropathies. Patients in the late-onset group more often showed involvement of the cervical spine (22.7% vs 9.7%; p = 0.03) and arthritis of the upper (13.6% vs 3.0%; p = 0.002) and lower limbs (27.3% vs 15.2%; p = 0.03) as first manifestations than did patients in the early-onset group. A higher percentage of mixed forms (axial and peripheral joint disease) during the course of the disease was also recorded in the late-onset group (50% vs 24%; p = 0.0001).
CONCLUSION: Our study suggests that age at onset of AS affects the patients' presenting clinical form. Arthritis of the upper limbs requires a differential diagnosis with other conditions frequent in patients over 50 years of age, such as rheumatoid arthritis or crystal-induced arthropathy.

Entities:  

Mesh:

Year:  2012        PMID: 22422491     DOI: 10.3899/jrheum.111082

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 2.  Spondyloarthritis with onset after age 45.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Angela Padula; Pietro Leccese; Carlo Palazzi
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

3.  Demographic, clinical, and laboratory features of Turkish patients with late onset ankylosing spondylitis.

Authors:  Ahmet Karaarslan; Hatice Yilmaz; Hakan Aycan; Mehmet Orman; Senol Kobak
Journal:  Bosn J Basic Med Sci       Date:  2015-07-22       Impact factor: 3.363

4.  A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Victoria Navarro-Compán; Christian Leyva Pardo; Xavier Juanola; Federico Navarro-Sarabia
Journal:  Rheumatol Int       Date:  2013-06-21       Impact factor: 2.631

Review 5.  Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations.

Authors:  Éric Toussirot
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

Review 6.  Management of inflammatory rheumatic conditions in the elderly.

Authors:  Clément Lahaye; Zuzana Tatar; Jean-Jacques Dubost; Anne Tournadre; Martin Soubrier
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

7.  Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis.

Authors:  Se Hee Kim; Hae-Rim Kim; Sang-Heon Lee; Kichul Shin; Hyoun-Ah Kim; Hong Ki Min
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

8.  Clinical, radiological, and magnetic resonance imaging characteristics of axial spondyloarthritis with late onset.

Authors:  Ho Yin Chung; Jin Xian Huang; Shirley Chiu Wai Chan; Kam Ho Lee; Helen Hoi Lun Tsang; Chak Sing Lau
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

9.  Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.

Authors:  Paloma Vela; Carlos Sanchez-Piedra; Carolina Perez-Garcia; María C Castro-Villegas; Mercedes Freire; Lourdes Mateo; Cesar Díaz-Torné; Cristina Bohorquez; Juan M Blanco-Madrigal; Inmaculada Ros-Vilamajo; Silvia Gómez; Rocio Caño; Fernando Sánchez-Alonso; Federico Díaz-González; Juan J Gómez-Reino
Journal:  Arthritis Res Ther       Date:  2020-06-15       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.